Final Program - Saturday October 7

Print
(Program subject to change)
Please click on the relevant day to view the applicable detailed program.

Saturday, October 7
Friday,
October 6
, 2017
Sunday,
October 8
, 2017
Saturday October 7, 2017
09:00 – 11:00
Session 1- Diabetes
Chairpersons: Baruch Itzhak, Israel & Dario Rahelic, Croatia
09:00 – 09:30
Debate: Universal or specific blood glucose targets: HbA1c <7.0 % (<53 mmol/mol) for all?
09:00-09:15
Yes: Philip Home, UK
09:15-09:30
No: Mehmet Ungan, Turkey
09:30-09:40
Discussion
09:40 – 10:20
Debate: Combination therapy – what is the best after metformin?
09:40-09:55
DPP4: Maja Racic, Bosnia and Herzegovina
09:55-10:10
SGLT2: Dario Rahelic, Croatia
10:10-10:20
Discussion
10:20 – 11:00
Debate: When, how and what type of insulin for Diabetes type II
10:20-10:35
Basal Insulin: Baruch Itzhak, Israel
10:35-10:50
Beyond basal Insulin: Xavier Cos Claramunt, Spain
10:50-11:00
Discussion
11:00 – 11:30
Coffee Break
11:30 – 12:30
Session 2 - Diabetes and Obesity
Chairperson: Xavier Cos Claramunt, Spain & Jarir Khury, Israel
Debate: Are all the GLP1 RA the same - Long acting Vs. Short acting?
11:30-11:50
Long acting: Eberhard Standl, Germany
11:50-12:10
Short acting: Katarina Lalic, Serbia
Debate: Approaches to obesity treatment - Pharmacological VS non-pharmacological
12:10-12:30
Pro Pharmacological Treatment: Nina Basic, Croatia
12:30-12:50
Con: Christos Lionis, Greece
12:50 – 13:30
Lunch
13:30 – 14:40
Session 3 - Challenges in COPD and Asthma
Chairperson: Ioanna Tsiligianni, Greece & Danica Rotar Pavlič,Slovenia
13:30-14:10
Debate: The role of inhaled corticosteroids in COPD
13:30-13:50
Dual bronchodilators (with no ICS) is better in patients with sever COPD: Ioanna Tsiligianni, Greece
13:50-14:10
Triple therapy with ICS is better in patients with severe COPD:
Alan Kaplan, Canada
14:10-14:40
Debate: Asthma control-management
14:10-14:25
Asthmatic patients who self manage do better: Alan Kaplan, Canada
14:25-14:40 Patients who have intensive physician involvement do better:
Catalina Panaitescu, Romania
14:40 – 15:30
Session 4 - New Therapeutics in Gastroenterology- Proton Pump Inhibitors (PPI)
Chairpersons: Juan Mendive, Spain & Hanny Yeshua, Israel
14:40-15:30
Debate: PPI a friend or a threat
14:40-15:00
A friend: Hanny Yeshua, Israel
15:00-15:20
A threat: Juan Mendive, Spain
15:20-15:30
Discussion
15:30 – 16:00
Coffee Break
16:00 – 17:10
Session 5 - Osteoporosis and Neuropathic Pain
16:00-16:05
Chairperson: Hanny Yeshua, Israel Ljubin Šukriev, Macedonia
Debate: Osteoporosis and Neuropathic Pain
16:05-16:20
Osteoporosis, Who will be screened?- Hanny Yeshua, Israel
16:20-16:35
Osteoporosis, Who needs treatment with a medication?- Blazenka Miskic, Croatia
16:35-16:55
Lecture: Combination therapy in Neuropathic pain -where is the evidence?- Hans Thulesius, Sweden
16:55-17:10
Discussion
17:15 – 19:00
Session 6- Stroke Prevention and Atrial Fibrillation
17:15-17:20
Chairpersons: Richard Hobbs, UK & Davor Milicic, Croatia
17:30-18:00
Debate: Novel anticoagulant therapy versus warfarin
17:30-17:45
Yes, for every patient:- Amnon Lahad, Israel
17:45-18:00
No, Warafin should be first choice:- Richard Hobbs, UK
18:00-18:15
Discussion
18:15-18:45
Debate: Should we use risk assessment tools ?
18:15-18:30
Yes: Davorka Vrdoljak, Croatia
18:30-18:45
No: Shlomo Vinker, Israel
18:45-19:00
Lecture: New drugs for CHF and the rule of diagnosis in primary care - Davor Milicic, Croatia